Impact of a Ten-Year National Italian Networking on Cardiac Complications in Patients with Thalassemia Major

Conclusion. Over a period of 10 years, the continuous monitoring of cardiac iron levels and a tailored chelation therapy allowed a reduction of MIO in the 70% of patients and a consequent improvement of cardiac function and reduction of heart failure. So, a national networking as the MIOT project was effective in improving the care and reducing cardiac outcomes of TM patients.Figure 1DisclosuresPepe: Chiesi Farmaceutici S.p.A., ApoPharma Inc., and Bayer: Other: No profit support.

Source: Blood - November 21, 2018 Category: Hematology Authors: Pepe, A., Pistoia, L., Maggio, A., Carra, A., Roberti, M. G., Bitti, P. P., Rosso, R., Caniglia, M., Mattei, R., Petrungaro, A. M., Riva, A., Righi, R., Positano, V., Meloni, A. Tags: 112. Thalassemia and Globin Gene Regulation: Poster I Source Type: research